| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 16584088
[patent_doc_number] => 20210018490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => COMPOSITIONS AND METHODS FOR INDIVIDUALIZED CHARACTERIZATION OF NON-IGE MEDIATED FOOD ALLERGIES
[patent_app_type] => utility
[patent_app_number] => 16/932227
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932227 | COMPOSITIONS AND METHODS FOR INDIVIDUALIZED CHARACTERIZATION OF NON-IGE MEDIATED FOOD ALLERGIES | Jul 16, 2020 | Pending |
Array
(
[id] => 16422267
[patent_doc_number] => 20200347465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => DETECTION OF SARS-COV-2 IN A PLURALITY OF BIOLOGICAL SAMPLES
[patent_app_type] => utility
[patent_app_number] => 16/932487
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932487 | DETECTION OF SARS-COV-2 IN A PLURALITY OF BIOLOGICAL SAMPLES | Jul 16, 2020 | Pending |
Array
(
[id] => 16621907
[patent_doc_number] => 20210040560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA
[patent_app_type] => utility
[patent_app_number] => 16/928436
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928436 | Methods for predicting risk of interstitial pneumonia | Jul 13, 2020 | Issued |
Array
(
[id] => 16525622
[patent_doc_number] => 20200399702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => METHODS OF PREDICTING PREDISPOSITION TO OR RISK OF KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/921287
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921287 | METHODS OF PREDICTING PREDISPOSITION TO OR RISK OF KIDNEY DISEASE | Jul 5, 2020 | Pending |
Array
(
[id] => 17897431
[patent_doc_number] => 20220307093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => OLIGONUCLEOTIDES FOR USE IN DETERMINING THE PRESENCE OF TRICHOMONAS VAGINALIS IN A SAMPLE
[patent_app_type] => utility
[patent_app_number] => 17/596786
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596786 | OLIGONUCLEOTIDES FOR USE IN DETERMINING THE PRESENCE OF TRICHOMONAS VAGINALIS IN A SAMPLE | Jul 1, 2020 | Pending |
Array
(
[id] => 19389870
[patent_doc_number] => 20240279740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA
[patent_app_type] => utility
[patent_app_number] => 18/004030
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004030 | METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA | Jul 1, 2020 | Pending |
Array
(
[id] => 16452988
[patent_doc_number] => 20200362414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Processes and Compositions for Methylation-Based Enrichment of Fetal Nucleic Acid From a Maternal Sample Useful for Non-Invasive Prenatal Diagnoses
[patent_app_type] => utility
[patent_app_number] => 16/915173
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/915173 | Processes and Compositions for Methylation-Based Enrichment of Fetal Nucleic Acid From a Maternal Sample Useful for Non-Invasive Prenatal Diagnoses | Jun 28, 2020 | Abandoned |
Array
(
[id] => 17750016
[patent_doc_number] => 20220228221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Diagnostics and Treatments Based Upon Molecular Characterization of Colorectal Cancer
[patent_app_type] => utility
[patent_app_number] => 17/596821
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596821 | Diagnostics and Treatments Based Upon Molecular Characterization of Colorectal Cancer | Jun 16, 2020 | Pending |
Array
(
[id] => 17642364
[patent_doc_number] => 20220170102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHOD FOR DETECTING SMN GENE COPY NUMBER USING SMNP AS REFERENCE
[patent_app_type] => utility
[patent_app_number] => 17/616996
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616996 | METHOD FOR DETECTING SMN GENE COPY NUMBER USING SMNP AS REFERENCE | May 31, 2020 | Abandoned |
Array
(
[id] => 16452599
[patent_doc_number] => 20200362025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 15/931452
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931452
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931452 | TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICES | May 12, 2020 | Pending |
Array
(
[id] => 16539303
[patent_doc_number] => 20200405716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 16/866137
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866137 | HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA | May 3, 2020 | Abandoned |
Array
(
[id] => 16484350
[patent_doc_number] => 20200377951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => FRATAXIN-SENSITIVE MARKERS FOR DETERMINING EFFECTIVENESS OF FRATAXIN REPLACEMENT THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/864125
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864125
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864125 | FRATAXIN-SENSITIVE MARKERS FOR DETERMINING EFFECTIVENESS OF FRATAXIN REPLACEMENT THERAPY | Apr 29, 2020 | Pending |
Array
(
[id] => 17807821
[patent_doc_number] => 20220259656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => BLOOD BIOMARKER AND GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CRTH2 RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/606232
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606232 | BLOOD BIOMARKER AND GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CRTH2 RECEPTOR ANTAGONISTS | Apr 27, 2020 | Abandoned |
Array
(
[id] => 17548553
[patent_doc_number] => 20220119894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => Systems and Methods for Targeting Dirofilaria immitis and Dirofilaria repens
[patent_app_type] => utility
[patent_app_number] => 17/605889
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605889 | Systems and Methods for Targeting Dirofilaria immitis and Dirofilaria repens | Apr 26, 2020 | Pending |
Array
(
[id] => 16343994
[patent_doc_number] => 20200308644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => USE OF GLYCANS AND GLYCOSYLTRANSFERASES FOR DIAGNOSING/MONITORING INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/847334
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847334
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847334 | USE OF GLYCANS AND GLYCOSYLTRANSFERASES FOR DIAGNOSING/MONITORING INFLAMMATORY BOWEL DISEASE | Apr 12, 2020 | Abandoned |
Array
(
[id] => 16361411
[patent_doc_number] => 20200318162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => GUT BACTERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND METHODS THEREWITH IN DETECTING ILEAL FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/832977
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832977 | GUT BACTERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND METHODS THEREWITH IN DETECTING ILEAL FIBROSIS | Mar 26, 2020 | Pending |
Array
(
[id] => 16657821
[patent_doc_number] => 20210054457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => AUTISM ASSOCIATED GENETIC MARKERS
[patent_app_type] => utility
[patent_app_number] => 16/826030
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826030 | AUTISM ASSOCIATED GENETIC MARKERS | Mar 19, 2020 | Abandoned |
Array
(
[id] => 16112379
[patent_doc_number] => 20200208212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => Processes and Compositions for Methylation-Based Enrichment of Fetal Nucleic Acid From a Maternal Sample Useful for Non-Invasive Prenatal Diagnoses
[patent_app_type] => utility
[patent_app_number] => 16/821863
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821863
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821863 | Processes and Compositions for Methylation-Based Enrichment of Fetal Nucleic Acid From a Maternal Sample Useful for Non-Invasive Prenatal Diagnoses | Mar 16, 2020 | Abandoned |
Array
(
[id] => 16284068
[patent_doc_number] => 20200277670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => TERTIARY AMINE SUBSTITUTED COUMARIN COMPOUNDS AND USES AS FLUORESCENT LABELS
[patent_app_type] => utility
[patent_app_number] => 16/805125
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805125
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805125 | Tertiary amine substituted coumarin compounds and uses as fluorescent labels | Feb 27, 2020 | Issued |
Array
(
[id] => 16270181
[patent_doc_number] => 20200271668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => METHODS FOR DIAGNOSING AND TREATING EOSINOPHILIC GASTRITIS
[patent_app_type] => utility
[patent_app_number] => 16/800390
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800390 | Methods for diagnosing and treating eosinophilic gastritis | Feb 24, 2020 | Issued |